I Gunther Eysenbach %V 9% N 5% P e36 %T基于手机的功能性胰岛素治疗1型糖尿病患者数据服务的可行性Kollmann,Alexander % a Riedl,Michaela % a Kastner,Peter % a Schreier,Guenter % a Ludvik,Bernhard +奥地利研究中心有限公司(ARC)，生物医学工程/电子健康系统，Reininghausstrasse 13/1，格拉茨，8020，奥地利，+43 (0)316 586570-11，guenter.schreier@arcsmed.at %K远程医疗%K糖尿病1型%K血糖自我监测%K手机%K互联网%D 2007 %7 31.12.2007 %9原始论文%J J医疗互联网Res %G英文%X背景:1型糖尿病(DM1)患者必须积极参与他们的治疗，因为他们不可避免地要负责自己的日常护理。移动互联网接入的可用性正在迅速发展，移动电话现在已广泛普及，价格低廉。因此，移动电话有可能协助糖尿病的日常管理，并使患者和医疗保健专业人员之间的远程医疗互动成为可能。目的:本研究旨在评估基于手机的数据服务辅助DM1患者强化胰岛素治疗的可行性和用户接受度。方法:基于Java 2 Mobile Edition开发了一款名为“糖尿病记忆”(diabi - memory)的应用软件，用于支持患者输入糖尿病相关数据，并与监测中心的远程数据库同步。然后对数据进行处理，生成统计数据和趋势，并通过Web门户向患者及其医疗保健专业人员提供这些数据。该系统已在临床前后试点试验过程中进行了评估。结果测量主要集中在患者对治疗的依从性、监测系统的可用性以及对代谢状态的影响。一般用户对系统的接受度通过问卷进行评估。 Results: Ten patients (four female) with DM1 participated in the trial. Mean age was 36.6 years (± 11.0 years) and prestudy glycated hemoglobin (HbA1c) was 7.9% (± 1.1%). A total of 3850 log-ins were registered during the 3 months of the study. The total number of received datasets was 13003, which equates to an average of 14 transmitted parameters per patient per day. The service was well accepted by the patients (no dropouts), and data transmission via mobile phone was successful on the first attempt in 96.5% of cases. Upon completion of the study, a statistically significant improvement in metabolic control was observed (HbA1c: prestudy 7.9% ± 1.1% versus poststudy 7.5% ± 0.9%;P= .02). While there was a slight decrease in average blood glucose level (prestudy 141.8 mg/dL ± 22.5 mg/dL vs poststudy 141.2 mg/dL ± 23.1 mg/dL;P= .69), the difference was not statistically significant. Conclusion: The results of the clinical pilot trial indicate that this proposed diabetes management system was well accepted by the patients and practical for daily usage. Thus, using the mobile phone as patient terminal seems to provide a ubiquitous, easy-to-use, and cost efficient solution for patient-centered data acquisition in the management of DM1. To confirm the promising results of the pilot trial further research has to be done to study long-term effects on glycemic control and cost-effectiveness. %M 18166525 %R 10.2196/jmir.9.5.e36 %U //www.mybigtv.com/2007/5/e36/ %U https://doi.org/10.2196/jmir.9.5.e36 %U http://www.ncbi.nlm.nih.gov/pubmed/18166525